Cerebrovascular events and outcomes in hospitalized patients with COVID-19: The SVIN COVID-19 Multinational Registry
James E Siegler,Pere Cardona,Juan F Arenillas,Blanca Talavera,Ana N Guillen,Alba Chavarría-Miranda,Mercedes de Lera,Priyank Khandelwal,Ivo Bach,Pratit Patel,Amit Singla,Manuel Requena,Marc Ribo,Dinesh V Jillella,Srikant Rangaraju,Raul G Nogueira,Diogo C Haussen,Alejandro R Vazquez,Xabier Urra,Ángel Chamorro,Luis S Román,Jesse M Thon,Ryna Then,Emma Sanborn,Natalia P de la Ossa,Mònica Millàn,Isaac N Ruiz,Ossama Y Mansour,Mohammed Megahed,Cristina Tiu,Elena O Terecoasa,Răzvan A Radu,Thanh N Nguyen,Gioacchino Curiale,Artem Kaliaev,Alexandra L Czap,Jacob Sebaugh,Alicia M Zha,David S Liebeskind,Santiago Ortega-Gutierrez,Mudassir Farooqui,Ameer E Hassan,Laurie Preston,Mary S Patterson,Saif Bushnaq,Osama Zaidat,Tudor G Jovin
DOI: https://doi.org/10.1177/1747493020959216
Abstract:Background: Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has been associated with a significant risk of thrombotic events in critically ill patients. Aim: To summarize the findings of a multinational observational cohort of patients with SARS-CoV-2 and cerebrovascular disease. Methods: Retrospective observational cohort of consecutive adults evaluated in the emergency department and/or admitted with coronavirus disease 2019 (COVID-19) across 31 hospitals in four countries (1 February 2020-16 June 2020). The primary outcome was the incidence rate of cerebrovascular events, inclusive of acute ischemic stroke, intracranial hemorrhages (ICH), and cortical vein and/or sinus thrombosis (CVST). Results: Of the 14,483 patients with laboratory-confirmed SARS-CoV-2, 172 were diagnosed with an acute cerebrovascular event (1.13% of cohort; 1130/100,000 patients, 95%CI 970-1320/100,000), 68/171 (40.5%) were female and 96/172 (55.8%) were between the ages 60 and 79 years. Of these, 156 had acute ischemic stroke (1.08%; 1080/100,000 95%CI 920-1260/100,000), 28 ICH (0.19%; 190/100,000 95%CI 130-280/100,000), and 3 with CVST (0.02%; 20/100,000, 95%CI 4-60/100,000). The in-hospital mortality rate for SARS-CoV-2-associated stroke was 38.1% and for ICH 58.3%. After adjusting for clustering by site and age, baseline stroke severity, and all predictors of in-hospital mortality found in univariate regression (p < 0.1: male sex, tobacco use, arrival by emergency medical services, lower platelet and lymphocyte counts, and intracranial occlusion), cryptogenic stroke mechanism (aOR 5.01, 95%CI 1.63-15.44, p < 0.01), older age (aOR 1.78, 95%CI 1.07-2.94, p = 0.03), and lower lymphocyte count on admission (aOR 0.58, 95%CI 0.34-0.98, p = 0.04) were the only independent predictors of mortality among patients with stroke and COVID-19. Conclusions: COVID-19 is associated with a small but significant risk of clinically relevant cerebrovascular events, particularly ischemic stroke. The mortality rate is high for COVID-19-associated cerebrovascular complications; therefore, aggressive monitoring and early intervention should be pursued to mitigate poor outcomes.